Delaying Second Dose of COVID-19 Vaccines: Considerations and Concerns
Concerns persist regarding the effectiveness of delaying the second dose of COVID-19 vaccines, especially in older adults, underscoring the need for evidence-based vaccination strategies and continued monitoring of vaccine efficacy and safety profiles.
November 2021
Asthma and COVID-19: Systematic Review and Meta-Analysis
Systematic review and meta-analysis evaluate the association between asthma and COVID-19 outcomes, providing comprehensive insights into the risk of infection, hospitalization, ICU admission, and mortality among asthmatic individuals during the pandemic.
November 2021
Reactive Infectious Mucocutaneous Rash in COVID-19: Case Report
A 17-year-old patient with confirmed SARS-CoV-2 infection presents with reactive infectious mucocutaneous rash, highlighting dermatological manifestations of COVID-19 and the importance of recognizing cutaneous symptoms in the diagnostic workup of suspected cases.
November 2021
Long-Term Post-Acute COVID Syndrome: Clinical Characteristics and Management
Long-term post-acute COVID syndrome is characterized by persistent symptoms and/or late complications beyond 4 weeks after acute infection, highlighting the need for multidisciplinary care and tailored interventions to address diverse clinical manifestations and functional impairments.
October 2021
Overweight and Obesity in COVID-19: Impact on Disease Severity
Higher body mass index shows a dose-response relationship with severe COVID-19 outcomes, underscoring the importance of obesity management and weight loss interventions in reducing disease severity and mitigating healthcare resource utilization in the pandemic.
October 2021
AstraZeneca Vaccine Clinical Trial Results in the US: Efficacy and Safety Profile
AstraZeneca vaccine demonstrates 100% efficacy in preventing severe cases and 79% efficacy in preventing COVID-19 symptoms, supporting its role in vaccination campaigns and contributing to global efforts to control the spread of the virus.
October 2021
Gastrointestinal Sequelae of COVID-19: Post-Discharge Symptoms
Gastrointestinal symptoms such as loss of appetite, nausea, acid reflux, and diarrhea persist in COVID-19 patients up to 3 months after discharge, highlighting the need for long-term monitoring and supportive care interventions in post-acute COVID-19 management.
October 2021
Risk of COVID-19 Transmission during Air Travel: Safety Precautions and Recommendations
Travelers should adhere to safety strategies, including mask-wearing, physical distancing, surface disinfection, and hand hygiene practices, to minimize COVID-19 transmission risks during air travel, supporting safe travel initiatives and public health measures.
June 2021
